摘要
目的探讨雷贝拉唑与莫沙必利治疗胆汁反流性胃炎的临床疗效以及药理分析。方法选取在大连大学附属新华医院就诊的80例胆汁反流性胃炎患者为研究对象,时间为2018年1月至2019年1月,随机分为试验组和对照组。两组均采用硫糖铝悬液凝胶常规治疗,对照组40例在此基础上加用奥美拉唑,试验组40例采取雷贝拉唑联合莫沙必利治疗,比较两组临床疗效。结果试验组患者的临床有效率95.00%,对照组临床有效率为80.00%,试验组高于对照组(P<0.05)。结论雷贝拉唑联合莫沙必利治疗胆汁反流性胃炎有效,改善临床症状,提高生活质量,适合临床推广应用。
Objective To investigate the clinical efficacy and pharmacological analysis of rabeprazole and mosapride in the treatment of bile reflux gastritis.Methods From January 2018 to January 2019 in Xinhua Hospital Affiliated to Dalian University,80 cases of bile reflux gastritis patients were randomly divided into experimental group and control group.Both groups were treated with sucralfate suspension gel conventionally.Forty cases in the control group were treated with omeprazole on this basis,and 40 cases in the experimental group were treated with rabeprazole combined with mosapride.The clinical effects of the two groups were compared.Results The clinical effective rate of the experimental group was 95.00%,and that of the control group was 80.00%,the experimental group was higher than the control group(P<0.05).Conclusion Rabeprazole combined with mosapride is effective in treating bile reflux gastritis,improving clinical symptoms and quality of life.
作者
秦薛
QIN Xue(Department of Pharmacy,Xinhua Hospital Affiliated to Dalian University,Dalian 116000,China)
出处
《中国医药指南》
2021年第30期72-73,共2页
Guide of China Medicine
